<?xml version="1.0" encoding="UTF-8"?>
<p>It was found that compound K, an intestinal microbiome metabolite of ginsenoside Rb1,
 <xref rid="med21743-bib-0342" ref-type="ref">
  <sup>342</sup>
 </xref> one of the major ginsenosides of Panax ginseng, has much stronger cancer chemopreventive activity than its precursor (Rb1 in HCT‐116 and HT‐19 human colorectal cancer cell lines), suggesting that Rb1 may have potential clinical significance in the prevention of inflammatory‐associated colorectal cancer
 <xref rid="med21743-bib-0343" ref-type="ref">
  <sup>343</sup>
 </xref> because of the regulation of the microbiome balance and compound K.
 <xref rid="med21743-bib-0343" ref-type="ref">
  <sup>343</sup>
 </xref>, 
 <xref rid="med21743-bib-0344" ref-type="ref">
  <sup>344</sup>
 </xref>
</p>
